Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel York

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Plos Genetics|May 20, 2026
An intronic variant in Ferredoxin Reductase (FDXR) creates a cryptic exon in Quarter Horses with Equine Juvenile Spinocerebellar AtaxiaBriana N Brown, Anna R Dahlgren, Sharmila Ghosh, et al.
Frontiers in Immunology|October 1, 2021
Comparative Immunogenomics of Canine Natural Killer Cells as Immunotherapy TargetAlicia A Gingrich, Taylor E Reiter, Sean J Judge, et al.
Veterinary and Comparative Oncology|August 30, 2018
Association of macrophage and lymphocyte infiltration with outcome in canine osteosarcomaSita S Withers, Katherine A Skorupski, Daniel York, et al.
Plos Genetics|May 13, 2016
Utilizing the Dog Genome in the Search for Novel Candidate Genes Involved in Glioma Development-Genome Wide Association Mapping followed by Targeted Massive Parallel Sequencing Identifies a Strongly Associated LocusKatarina Truvé, Peter Dickinson, Anqi Xiong, et al.
Veterinary Oncology (London, England)|October 3, 2025
Evaluating the impact of doxorubicin preconditioning on the efficacy of inhaled recombinant human IL-15 immunotherapy in dogs with pulmonary metastasisMadison E Luker, Daniel York, Sami Al-Nadaf, et al.
Plos Genetics|December 7, 2018
Whole genome variant association across 100 dogs identifies a frame shift mutation in DISHEVELLED 2 which contributes to Robinow-like syndrome in Bulldogs and related screw tail dog breedsTamer A Mansour, Katherine Lucot, Sara E Konopelski, et al.
Veterinary and Comparative Oncology|May 31, 2023
Establishment and characterization of two novel patient-derived lines from canine high-grade gliomaMorgan S Schrock, Abigail A Zalenski, Miranda M Tallman, et al.
Cancer Cell|August 29, 2025
Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancerJennifer R Grandis, Katherine A Skorupski, Ning Cheng, et al.
Journal for Immunotherapy of Cancer|June 9, 2022
Inhaled recombinant human IL-15 in dogs with naturally occurring pulmonary metastases from osteosarcoma or melanoma: a phase 1 study of clinical activity and correlates of responseRobert B Rebhun, Daniel York, Sylvia Margret Cruz, et al.
Frontiers in Immunology|November 10, 2025
Phase 2 trial (NCI-COTC030) of adjuvant inhaled recombinant human IL-15 combined with amputation and adjuvant chemotherapy in dogs with appendicular osteosarcomaRobert B Rebhun, Sylvia M Cruz, Daniel York, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Plos Genetics|May 20, 2026
An intronic variant in Ferredoxin Reductase (FDXR) creates a cryptic exon in Quarter Horses with Equine Juvenile Spinocerebellar AtaxiaBriana N Brown, Anna R Dahlgren, Sharmila Ghosh, et al.
Frontiers in Immunology|October 1, 2021
Comparative Immunogenomics of Canine Natural Killer Cells as Immunotherapy TargetAlicia A Gingrich, Taylor E Reiter, Sean J Judge, et al.
Veterinary and Comparative Oncology|August 30, 2018
Association of macrophage and lymphocyte infiltration with outcome in canine osteosarcomaSita S Withers, Katherine A Skorupski, Daniel York, et al.
Plos Genetics|May 13, 2016
Utilizing the Dog Genome in the Search for Novel Candidate Genes Involved in Glioma Development-Genome Wide Association Mapping followed by Targeted Massive Parallel Sequencing Identifies a Strongly Associated LocusKatarina Truvé, Peter Dickinson, Anqi Xiong, et al.
Veterinary Oncology (London, England)|October 3, 2025
Evaluating the impact of doxorubicin preconditioning on the efficacy of inhaled recombinant human IL-15 immunotherapy in dogs with pulmonary metastasisMadison E Luker, Daniel York, Sami Al-Nadaf, et al.
Plos Genetics|December 7, 2018
Whole genome variant association across 100 dogs identifies a frame shift mutation in DISHEVELLED 2 which contributes to Robinow-like syndrome in Bulldogs and related screw tail dog breedsTamer A Mansour, Katherine Lucot, Sara E Konopelski, et al.
Veterinary and Comparative Oncology|May 31, 2023
Establishment and characterization of two novel patient-derived lines from canine high-grade gliomaMorgan S Schrock, Abigail A Zalenski, Miranda M Tallman, et al.
Cancer Cell|August 29, 2025
Safety and efficacy of a STAT3-targeted cyclic oligonucleotide: From murine models to a phase 1 clinical trial in pet cats with oral cancerJennifer R Grandis, Katherine A Skorupski, Ning Cheng, et al.
Journal for Immunotherapy of Cancer|June 9, 2022
Inhaled recombinant human IL-15 in dogs with naturally occurring pulmonary metastases from osteosarcoma or melanoma: a phase 1 study of clinical activity and correlates of responseRobert B Rebhun, Daniel York, Sylvia Margret Cruz, et al.
Frontiers in Immunology|November 10, 2025
Phase 2 trial (NCI-COTC030) of adjuvant inhaled recombinant human IL-15 combined with amputation and adjuvant chemotherapy in dogs with appendicular osteosarcomaRobert B Rebhun, Sylvia M Cruz, Daniel York, et al.
Pageof 3